Negative modulation of inositol 1,4,5-trisphosphate type 1 receptor expression prevents dystrophin-deficient muscle

Ludivine Mondin1, Haouaria Balghi, Bruno Constantin

  • 1Institut de Physiologie et Biologie Cellulaires, Centre National de la Recherche Scientifique UMR 6187, Université de Poitiers, 86022 Poitiers, France.

Insights

Cyclosporin A (CsA) modulates calcium signaling in dystrophin-deficient cells, reducing inositol 1,4,5-trisphosphate receptor activity and improving cell survival. This suggests CsA as a potential therapeutic for cell death in these conditions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Dystrophin-deficient cells exhibit dysregulated calcium (Ca2+) signaling, characterized by overactive inositol 1,4,5-trisphosphate (IP3) receptor-mediated Ca2+ release.
  • Restored calcium homeostasis was previously observed in these cells upon forced expression of mini-dystrophin.

Purpose of the Study:

  • To investigate the modulatory effects of cyclosporin A (CsA) on calcium signaling and cell survival in dystrophin-deficient cells.
  • To explore the potential of inhibiting the IP3 pathway as a therapeutic strategy.

Main Methods:

  • Exposure of dystrophin-deficient cells to CsA for varying durations.
  • Measurement of IP3-dependent calcium release.
  • Analysis of IP3 receptor type 1 (IP3R-1) RNA levels.
  • Assessment of cell survival following IP3R-1 knockdown or blockade.

Main Results:

  • Short-term CsA incubation decreased IP3-dependent calcium release, mimicking effects of mini-dystrophin expression.
  • Long-term CsA incubation reduced IP3R-1 RNA levels.
  • IP3R-1 knockdown or blockade, including via CsA, enhanced dystrophin-deficient myotube survival.
  • Cell death was demonstrated to be dependent on IP3-mediated calcium signaling.

Conclusions:

  • CsA exerts a dual modulatory effect on calcium signaling in dystrophin-deficient cells.
  • Inhibition of the IP3 pathway, through CsA or other methods, promotes survival of dystrophin-deficient myotubes.
  • Targeting the IP3 pathway represents a promising approach to mitigate cell death in dystrophinopathies.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...